BioCentury
ARTICLE | Clinical News

Topotecan: Phase I; marketed to treat ovarian cancer and small cell lung cancer (SCLC)

April 21, 2003 7:00 AM UTC

IEX partner GSK filed an IND to start a U.S. Phase I trial. ...